ALPHA TEKNOVA, INC. Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net
ALPHA TEKNOVA, INC. (TKNO) reported Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net of -$158.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet · last filed 2026-08-06
- ALPHA TEKNOVA, INC. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2026-06-30 was -$68.00K, a 334.48% decline year-over-year.
- ALPHA TEKNOVA, INC. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2026-03-31 was -$90.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2025-12-31 was -$30.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2025-09-30 was -$33.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2025 was -$97.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2024 was -$470.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2023 was -$400.00K, a 119.31% decline from fiscal 2022.
- ALPHA TEKNOVA, INC. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2022 was $2.07M, a 1228.21% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$158.00K 10-Q · filed 2026-08-06 | -$188.00K derived: sum of 3 quarters · filed 2026-08-06 | -$221.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$90.00K 10-Q · filed 2026-05-07 | -$120.00K derived: sum of 2 quarters · filed 2026-05-07 | -$153.00K derived: sum of 3 quarters · filed 2026-05-07 | -$124.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$63.00K derived: sum of 2 quarters · filed 2026-03-02 | -$34.00K derived: sum of 3 quarters · filed 2026-08-06 | -$97.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$4.00K derived: sum of 2 quarters · filed 2026-08-06 | -$67.00K 10-Q · filed 2025-11-07 | -$203.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$34.00K 10-Q · filed 2026-08-06 | -$170.00K derived: sum of 3 quarters · filed 2026-08-06 | -$298.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$63.00K 10-Q · filed 2026-05-07 | -$199.00K derived: sum of 2 quarters · filed 2026-05-07 | -$327.00K derived: sum of 3 quarters · filed 2026-05-07 | -$416.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$264.00K derived: sum of 2 quarters · filed 2026-03-02 | -$353.00K derived: sum of 3 quarters · filed 2026-03-02 | -$470.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | -$128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$217.00K derived: sum of 2 quarters · filed 2025-11-07 | -$334.00K 10-Q · filed 2025-11-07 | -$434.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$206.00K 10-Q · filed 2025-08-08 | -$306.00K derived: sum of 3 quarters · filed 2025-08-08 | -$384.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$117.00K 10-Q · filed 2025-05-09 | -$217.00K derived: sum of 2 quarters · filed 2025-05-09 | -$295.00K derived: sum of 3 quarters · filed 2025-05-09 | -$415.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$178.00K derived: sum of 2 quarters · filed 2025-03-07 | -$298.00K derived: sum of 3 quarters · filed 2025-03-07 | -$400.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | -$78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$198.00K derived: sum of 2 quarters · filed 2024-11-08 | -$300.00K 10-Q · filed 2024-11-08 | $776.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$222.00K 10-Q · filed 2024-08-13 | $854.00K derived: sum of 3 quarters · filed 2024-08-13 | $1.26M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$102.00K 10-Q · filed 2024-05-13 | $974.00K derived: sum of 2 quarters · filed 2024-05-13 | $1.38M derived: sum of 3 quarters · filed 2024-05-13 | $1.75M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $1.48M derived: sum of 2 quarters · filed 2024-03-27 | $1.86M derived: sum of 3 quarters · filed 2024-03-27 | $2.07M 10-K · filed 2024-03-27 |
| 2022-09-30 | $407.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $780.00K derived: sum of 2 quarters · filed 2023-11-13 | $996.00K 10-Q · filed 2023-11-13 | $1.15M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $373.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $589.00K 10-Q · filed 2023-08-11 | $740.00K derived: sum of 3 quarters · filed 2023-08-11 | |
| 2022-03-31 | $216.00K 10-Q · filed 2023-05-11 | $367.00K derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $156.00K 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $5.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |